Mechanism of Guilu Erxian ointment based on targeted metabolomics in intervening in vitro fertilization and embryo transfer outcome in older patients with poor ovarian response of kidney-qi deficiency type.

Ma Y, Song J, Cao X, Sun Z

Open source

DOI
10.3389/fendo.2023.1045384
Published
2023
Container
Frontiers in endocrinology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fendo.2023.1045384,
  title = {Mechanism of Guilu Erxian ointment based on targeted metabolomics in intervening in vitro fertilization and embryo transfer outcome in older patients with poor ovarian response of kidney-qi deficiency type.},
  author = {Ma Y and Song J and Cao X and Sun Z},
  year = {2023},
  journal = {Frontiers in endocrinology},
  doi = {10.3389/fendo.2023.1045384},
  url = {https://doi.org/10.3389/fendo.2023.1045384}
}

RIS

TY  - JOUR
TI  - Mechanism of Guilu Erxian ointment based on targeted metabolomics in intervening in vitro fertilization and embryo transfer outcome in older patients with poor ovarian response of kidney-qi deficiency type.
AU  - Ma Y
AU  - Song J
AU  - Cao X
AU  - Sun Z
PY  - 2023
JO  - Frontiers in endocrinology
DO  - 10.3389/fendo.2023.1045384
UR  - https://doi.org/10.3389/fendo.2023.1045384
ER  - 

APA

Y, M., J, S., X, C., & Z, S. (2023). Mechanism of Guilu Erxian ointment based on targeted metabolomics in intervening in vitro fertilization and embryo transfer outcome in older patients with poor ovarian response of kidney-qi deficiency type.. Frontiers in endocrinology. https://doi.org/10.3389/fendo.2023.1045384

Source records